Ousting RAGE in melanoma: A viable therapeutic target?
Ousting RAGE in melanoma: A viable therapeutic target?
复制标题
DOI:
10.1016/j.semcancer.2017.10.008
复制
发表时间:
2018-04
影响因子:
14.5
通讯作者:
Mukhtar H
中科院分区:
文献类型:
--
作者:
Syed DN;Aljohani A;Waseem D;Mukhtar H
Melanoma remains an important health concern, given the steady increase in incidence and acquisition of resistance to systemic therapies. The receptor for advanced glycation end products (RAGE) initially identified for its binding to advanced glycation end products was subsequently acknowledged as a pattern recognition receptor given its ability to recognize similar structural elements within numerous ligands. Recent studies have elucidated a plausible role of RAGE in melanoma progression through modulation of inflammatory, proliferative and invasive cellular responses. Several of its ligands including the S100 proteins and HMGB1 are being investigated for their involvement in melanoma metastasis and as potential biomarkers of the disease. Targeting RAGE signaling represents a viable therapeutic strategy which remains underexplored in cutaneous malignancies. Here we have summarized current knowledge on the functionality of RAGE with special focus on specific ligands enumerated in various in vitro and in vivo melanoma models.
登录
查看更多内容
DOI:
10.1016/j.str.2010.05.017
发表时间:
2010-10-13
期刊:
Structure (London, England : 1993)
影响因子:
--
作者:
Koch M;Chitayat S;Dattilo BM;Schiefner A;Diez J;Chazin WJ;Fritz G
通讯作者:
Fritz G
影响因子:
1.6
作者:
Hoppmann, Susan;Haase, Cathleen;Pletzsch, Jens
通讯作者:
Pletzsch, Jens
影响因子:
4.8
作者:
Lin, Jing;Yang, Qingyuan;Weber, David J.
通讯作者:
Weber, David J.
DOI:
10.1016/j.bbrc.2011.08.132
发表时间:
2011-09-30
影响因子:
3.1
作者:
Haase-Kohn, Cathleen;Wolf, Susann;Pietzsch, Jens
通讯作者:
Pietzsch, Jens
影响因子:
5.3
作者:
Herwig N;Belter B;Wolf S;Haase-Kohn C;Pietzsch J
通讯作者:
Pietzsch J